ORAGENICS INC
For the period ended Jun 30, 2024. Filed Aug 9, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 9, 2024
OGEN$0.35+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ITEM 6. | EXHIBITS |
|---|
Incorporated by reference to Exhibits filed after signature page.
EXHIBIT INDEX
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit number · Exhibit description · Form · File no. · Exhibit · Filing date · Filed herewith | |||||
| 1.1 | Placement Agency Agreement dated June 25, 2024 between Oragenics, Inc. and Dawson James Securities, Inc. | 8-K | 001-32188 | 1.1 | 6/26/24 |
| 3.1 | Amended and Restated Articles of Incorporation as amended prior to December 29, 2017 (including certificates of designation of Series A, B and C Preferred Stock). | 8-K | 001-32188 | 3.1 | 12/29/17 |
| 3.2 | Articles of Amendment to Amended and Restated Articles of Incorporation dated effective December 29, 2017. | 8-K | 001-32188 | 3.2 | 12/29/17 |
| 3.3 | Articles of Amendment to Amended and Restated Articles of Incorporation effective January 19, 2018. | 8-K | 001-32188 | 3.1 | 1/19/18 |
| 3.4 | Articles of Amendment to Amended and Restated Articles of Incorporation. | 8-K | 001-32188 | 3.4 | 6/26/18 |
| 3.5 | Articles of Amendment to Amended and Restated Articles of Incorporation | 8-K | 001-32188 | 3.5 | 2/28/22 |
| 3.6 | Articles of Amendment to Amended and Restated Articles of Incorporation | 8-K | 001-32188 | 3.1 | 1/23/23 |
| 3.7 | Amendment to Articles of Incorporation for Certificate of Designation of Series F Convertible Preferred Stock | 8-K | 001-32188 | 3.1 | 12/8/23 |
| 3.8 | Amendment to Articles of Incorporation to Increase Common Stock | 8-K | 001-32188 | 3.1 | 12/15/23 |
| 3.9 | Bylaws | SB-2 | 333-100568 | 3.2 | 10/16/02 |
| 3.10 | First Amendment to Bylaws | 8-K | 001-32188 | 3.1 | 6/9/10 |
| 3.11 | Second Amendment to Bylaws | 8-K | 001-32188 | 3.1 | 8/24/10 |
| 3.12 | Third Amendment to Bylaws | 8-K | 001-32188 | 3.9 | 2/28/22 |
| 10.1 | At-The-Market Issuance Sales Agreement between the Company and Ascendiant Capital Markets, LLC dated August 8, 2024 | X |
| 31.1 | Certification of Principal Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended. | X |
| 31.2 | Certification of Principal Financial Officer pursuant to Rule 13a-14 and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended. | X |
| 32.1 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer). ** | X |
| 32.2 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer). ** | X |
| 101.INS | Inline XBRL Instance Document | |
| 101.SCH | Inline XBRL Taxonomy Extension Schema | X |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | X |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | X |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | X |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | X |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document |
*Portions of the exhibits have been omitted pursuant to Item 601(b)(10)(iv).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.